At the end of ICU stay, success was present in 51 pts (71.8%). Median stay in the ICU after levosimendan administration was 4 [IQR:1-9] days. A betablocker and an ACE inhibitor were given in 43.1% and 74.5% respectively.
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Predictors of in hospital mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery Batric Popovic [Orateur] (1), Claire Lalevée (1), Charles Christophe (1), Michael Angioi (2), Bruno Levy (3), Etienne Aliot (1) (1) CHU Brabois, Cardiologie, Vandoeuvre Les Nancy, CHU Brabois, Vandoeuvre Les Nancy, CHU Brabois, Réanimation Médicale, Vandoeuvre Les Nancy, France Objectives: We sought to evaluate the impact of post-primary percutaneous coronary intervention (PCI) patent artery in the infarct-related artery in patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock.
Background:
Little is known about predictors of survival in patients with persistent shock following STEMI despite a patent infarct artery.
Methods: This retrospective monocentric study included consecutive patients with an early cardiogenic shock complicating STEMI from 2007 to 2010 in our center.
All these patients underwent early PCI: ie up to 36 h from symptoms and only patients with infarct artery patency defined as final TIMI 3 flow were included.
Results: Between 2007 and 2010, 832 patients underwent primary PCI for acute STEMI. We studied specifically a cohort of 84 patients with cardiogenic shock with post-procedure patent TIMI 3 infarct related artery.
The mean age of the patients was 64±13 years. The delay between STEMI diagnosis and cardiogenic shock and open infarct related artery were 4.5 hours and 7 hours respectively. 95% of patients underwent revascularization of the culprit lesion and multisite PCI was performed in 7% of cases.
After PCI, mechanical ventilation was used in 80% of cases and all patients needed inotropes drugs. In two cases, a percutaneous ECMO support was decided.
The in-hospital mortality rate was 44 %. In univariate analysis, pulmonary insufficiency characterized by ratio PaO2/FIO2 (p=0,02), increased serum creatinine (SCr) from baseline-25% (p=0,01) and level of lactates (p<0,01) were significantly associated with increased in hospital mortality.
In multivariate analysis, the ratio PaO2/FIO2 and an increased SCr were independent predictors of in hospital mortality.
At 6 months, the mortality rate was 46%. We noted a coronary revascularization in 6 cases, a implantable cardioverter-defibrillator in 3 cases and a left ventricular ejection fraction -35% in 20 % of patients. Introduction: Massive pulmonary embolism is defined as occlusion of more than 50% of the pulmonary vasculature or occlusion of two or more lobar arteries.
Conclusion

Purpose of work:
Describe the clinical features, paraclinical findings and prognosis of patients with massive pulmonary embolism.
Materials and methods:
It is a single-center study, retrospective, covering 145 patients hospitalized in the emergency department of the hospital Habib Thameur in the period from January 2000 to December 2007 with a pulmonary embolism. We divided our patients into 2 groups: one group with a massive pulmonary embolism (MPG+) and a group without (MPG-).
Results:
The diagnosis of massive pulmonary embolism was retained in 23 patients that is 21.3%. no features patient's specificities (age, sex and underlying pulmonary defects) were significantly related to massive pulmonary embolism. Clinical examination showed that (MPG+) had a respiratory rate (RR) and heart rate (HR) significantly higher than the (MPG-) ( average RR: 27 vs 23, P=0.03) (average HR: 104 vs. 95, P=0.02) .The report PaO2 / FIO2 was significantly lower in the (MPG+) (304 vs. 358, P=0.02). The transthoracic echocardiography was performed in 42 patients (8: MPG+ and 24: MPG-), the echocardiographic characteristics which were significantly associated with massive pulmonary embolism were: right ventricular dilation (P=0.04) and pulmonary artery hypertention (P=0.0006). Massive pulmonary embolism was not significantly related to hospital mortality.
Conclusion:
Massive pulmonary embolism does not prejudge the outcome nether clinical consequences nor the prognostic for the patient.
